EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy

Lisamaura Tulimiero iD, Brigida Boccanegra iD, Paola Mantuano iD, Antonietta Mele, Michela De Bellis, Roberta Lenti iD, Francesca Sanarica, Santa Cirmi, Elena Conte, Ornella Cappellari iD, Amber E Sherrard, Ardawna Green und 3 weitere

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Lisamaura Tulimiero und 14 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Bari, Italy. Hauptthemen laut MEDLINE: Citrulline, Muscular Dystrophy, Duchenne, Diaphragm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Duchenne Parent Project, Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose The absence of the protein dystrophin in Duchenne muscular dystrophy (DMD) leads to progressive muscle weakness, failing regeneration and deregulation of nitric oxide (NO) signalling. We focused on L‐citrulline, a precursor of L‐arginine, required for NO production in muscle, which is reduced in dystrophic mdx muscle. Experimental Approach L‐Citrulline was administered (2 mg g −1 die −1 ), through diet, in comparison and/or in combination with prednisolone (1 mg kg −1 , 5 days per week subcutaneously) to 4‐ to 5‐week‐old mdx mice for 8 weeks. Key Results L‐Citrulline increased the levels of L‐arginine, L‐citrulline and L‐ornithine in plasma and quadriceps of mdx mice. L‐citrulline, alone or plus prednisolone, significantly improved maximal forelimb force in vivo, while ameliorating diaphragm movement amplitude and reducing diaphragm echodensity. In parallel, ex vivo, we detected a significant improvement of diaphragm force and contraction kinetics in mice treated with L‐citrulline alone or in combination with prednisolone. L‐citrulline also restored the expression of genes involved in Ca 2+ handling during contraction ( RyR1 , RyR3 and SERCA ), while reducing the markers of inflammation and fibrosis ( CD68 and TGFβ1 ) and ameliorating mitochondrial biogenesis‐associated genes ( PGC1‐α and MEF2C ). No effect was observed on S‐nitrosylation levels of HDAC2 and on diaphragm and gastrocnemius nNOS gene expression, suggesting a NO‐independent mechanism underlying the positive outcome observed. Conclusions Our results revealed the ability of L‐citrulline supplementation to ameliorate in vivo and ex vivo function of diaphragm muscle, highlighting novel metabolic and calcium‐related mechanisms of potential clinical interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CitrullineMuscular Dystrophy, DuchenneDiaphragmAnimalsMice, Inbred mdxMiceMaleArgininePrednisoloneOrnithineMice, Inbred C57BLMuscle ContractionNitric Oxide

Stichwörter der Autor:innen

Duchenne muscular dystrophyL‐arginineL‐citrullinecalcium handlingdiaphragmnitric oxide

Substanzen

CitrullineArgininePrednisoloneOrnithineNitric Oxide

Autor:innen und Institutionen

  • Section of Pharmacology, Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Bari, Italy.
  • USDA/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Lisamaura Tulimiero, Brigida Boccanegra, Paola Mantuano, Roberta Lenti, Ornella Cappellari

Förderung

  • Duchenne Parent Project
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Tulimiero, L., Boccanegra, B., Mantuano, P., Mele, A., De Bellis, M., Lenti, R., Sanarica, F., Cirmi, S., Conte, E., Cappellari, O., Sherrard, A. E., Green, A., Srinivasa, M., Fiorotto, M. L., & De Luca, A. (2026). Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy. British Journal of Pharmacology. https://doi.org/10.1111/bph.70437

Vancouver

Tulimiero L, Boccanegra B, Mantuano P, Mele A, De Bellis M, Lenti R, et al. Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy. British Journal of Pharmacology. 2026. doi:10.1111/bph.70437

BibTeX
@article{Tulimiero2026,
  author = {Tulimiero, Lisamaura and Boccanegra, Brigida and Mantuano, Paola and Mele, Antonietta and De Bellis, Michela and Lenti, Roberta and Sanarica, Francesca and Cirmi, Santa and Conte, Elena and Cappellari, Ornella and Sherrard, Amber E and Green, Ardawna and Srinivasa, Mira and Fiorotto, Marta L and De Luca, Annamaria},
  title = {Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70437}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche